CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 262 filers reported holding CLOVIS ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $200,000 | -68.6% | 28,584 | -71.4% | 0.02% | -75.4% |
| Q1 2020 | $636,000 | -91.3% | 100,054 | +28.6% | 0.07% | -37.3% |
| Q2 2017 | $7,284,000 | +1256.4% | 77,800 | +177.9% | 0.11% | +323.1% |
| Q1 2016 | $537,000 | -90.6% | 28,000 | -55.1% | 0.03% | -94.0% |
| Q3 2015 | $5,738,000 | +2484.7% | 62,400 | +1980.0% | 0.43% | +1957.1% |
| Q1 2015 | $222,000 | -40.6% | 3,000 | -44.4% | 0.02% | +16.7% |
| Q1 2014 | $374,000 | +68.5% | 5,400 | +45.9% | 0.02% | -14.3% |
| Q4 2013 | $222,000 | – | 3,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
| Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
| Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
| Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
| Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
| Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
| Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
| SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
| Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |